PhD Mabel Loza (BioFarma Group coordinator) assisted to VI Jornada: Anticipando la medicina del futuro, that was be celebrated last 14of December in Madrid.
More info
Published in Web (15/12/2023)
XXXVI Congreso ENCIGA
24 November 2023
PhD Mabel Loza (BioFarma Group coordinator) assisted to
XXXVI Congreso ENCIGA, that was be celebrated last 24 of November inXinzo de Limia.
More info
Published in Web (23/11/2023)
EU-OPENSCREEN - AUTUMN TRAINING SCHOOL 2023
20 November 2023
PhD Mabel Loza (BioFarma Group coordinator) and PhD Pepo
Brea, assisted to EU-OPENSCREEN - AUTUMN TRAINING SCHOOL 2023, that was be celebrated online from 20 to 22 of November.
More info
Published in Web (23/11/2023)
Spanish Drug Discovery Network Meeting
20 November 2023
PhD Mabel Loza (BioFarma Group coordinator) and PhD Geert
Daudey, assisted to Spanish Drug Discovery Network Meeting, that was be celebrated from 20 to 21 of November in Barcelona
More info
Published in Web (22/11/2023)
Conference on personalised medicine: The evolution of healthcare to improve people´s lives
4 October 2023
PhD Mabel Loza (BioFarma Group coordinator) assisted to Conference on personalised medicine: The evolution of healthcare to improve people´s lives, that was be celebrated from 4 to 5 of October in Valencia.
More info
Published in Web (6/10/2023)
The evolution of healthcare to improve people´s lives
26 September 2023
PhD Mabel Loza (BioFarma Group coordinator),
participated in The evolution of healthcare to improve people´s lives, that was be celebrated last 4 of October in Valencia
More info
Published in Web (7/10/2023)
XL National Meeting of the Spanish Society of Pharmacology
6 September 2023
PhD Mabel Loza (BioFarma Group coordinator),
PhDs Antón Leandro Martínez and Jose Manuel Brea and the predoctoral student Daniel López Fernández assisted to XL National Meeting of the Spanish Society
of Pharmacology, that was celebrated last 6 of september in Toledo.
More info
Published in Web (10/09/2023)
Biospain 2023
26 September 2023
PhD Mabel Loza (BioFarma Group coordinator),
and PhD Laura Gómez assisted to Biospain, that was be celebrated next 26 of september in Barcelona
More info
Published in Web (20/09/2023)
19TH world
congress of basic & clinical pharmacology
2 July 2023
PhDs Mabel Loza (BioFarma Group coordinator), Shannon Amy Jenkins, Neila Cosme and Mateo Barro from Biofarma Group assisted to
19TH world congress of basic & clinical pharmacology that was celebrated from 2 to 7 of july in the Glasgow.
See program
Published in Web (25/01/2023)
Innovación multidisciplinar en medicina personalizada
31 May 2023
PhD Mabel Loza (BioFarma Group Coordinator) and PhD Laura Gómez participed in "Innovación multidisciplinar en medicina personalizada" that was celebrated last 31 of may in the Centro d eSalud Carlos III.
More info
Published in Web (1/06/2023)
XVI Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica
23 May 2023
Jose Manuel Santamaría from BioFarma Group participed in "XVI Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica" that was celebrated last 23 of may in the Auditorio Rafael del Pino (Madrid).
More info
Published in Web (26/05/2023)
Plastic Health Summit 2023
11 May 2023
Phds Inés Ardao and Geert Daudey from Biofarma Group assisted to Plastic Health Summit 2023 that was celebrated last 11th May in Bruselas.
Click to more info
Published in Web (12/05/2023)
1st Workshop on Radio- and Nano-oncology & EuroNanoMed3 RAIN meeting
27th April 2023
PhD Mabel Loza (BioFarma Group Coordinator) participed to 1st Workshop on Radio- and Nano-oncology & EuroNanoMed3 RAIN meeting that was celebrated last 27 and 28 of april in the CIMUS building.
See program
Published in Web (14/04/2023)
Premios de investigación en nefrología de la Fundación Real Íñigo Álvarez de
Toledo
7 January 2023
This Monday our coordinator, Mabel Loza, attended the award ceremony of the nephrology
research prizes of the Fundación Real Íñigo Álvarez de Toledo whose jury is chaired by.
Congratulations to the award winners and to the Foundation for its admirable work for more than forty years.
Click aquí para más info
PICTURES
Published in Web (07/01/2023)
WORKSHOP SEF: Targeting neuroinflammation for SNC treatment Disorders
25 January 2023
PhDs Mabel Loza (BioFarma Group coordinator), Pepo Brea and Antón Leandro Martínez from Biofarma Group assisted to
WORKSHOP SEF: Targeting neuroinflammation for SNC treatment Disorders that was celebraed last 25 of january in the Faculty of Chemistry (Universidad Autónoma de
Madrid).
PhD Mabel Loza participated with the meeting:Drug screening in neuropathic pain employing phenotypic neuronal-like models
More info
PICTURES
Published in Web (25/01/2023)
EU-OPENSCREEN ACADEMIC COMPOUNDS INITIATIVE
15th December 2022
PhD Mabel Loza (Coordinadora del
BioFarma Group Coordinator) assisted online to EU-OPENSCREEN ACADEMIC COMPOUNDS INITIATIVE that was celebrated last 12 of december
in the Centro de Investigación Príncipe Felipe in Valencia.
See program
Pubshed in Web (16/12/2022)
SESIONES DE INVESTIGACIÓN IISGS
15 December 2022
Phd Mabel Loza (BioFarma Group Coordinator) participates in Sesiones de investigación IISGS in Vigo with the meeting Descubriendo fármacos
traslacionales, las sinergias en innovación abierta.
PICTURES
Published in Web (16/12/2022)
XIV Spanish Drug Discovery Network Meeting
24 November 2022
Phd Geert Daudey (
(BioFarma Group)) assisted to the XIV Spanish Drug Discovery Network Meeting that was celebrated last 24 of November in Granada.
Alba Paz Castro (Biofarma Group Predoctoral Student) participated with a poster in the 1st FEBS-IUBMB-ENABLE Conference that was celebrated in Seville.
PICTURES
Published in Web (18/11/2022)
3rd Consortium meeting and Training Course in Aachen
19 October 2022
Phd Mabel Loza (BioFarma Group Coordinator) and Phd Pepo Brea
participated last 17th of October in the 3rd Consortium meeting and Training Course that was held in Aachen.
More info:
Web project Drugtrain
Published in Web (19/10/2022)
Alba Paz Castro, first prize for the best poster in the
2nd Transatlantic ECI GPCR Symposium
21 Julio 2022
Alba Paz Castro, TFM Student from Molecular Pharmacology of G protein-coupled receptors group that defended last 19th of June her TFM "Expandindo a farmacoloxía do
receptor CX3CR1 de fractalquina: caracterización da variante natural rara Ala55Thr do receptor asociada a esquizofrenia", won the first prize for the best poster at the 2nd Transatlantic ECI GPCR Symposium celebrated virtually last 16th and 17th of July.
PICTURES
Published in Web (21/07/2022)
Gerardo Turcatti Seminar: Implementing high-content screens using models
generated with patients-derived cells
15 July 2022
The Seminar: Implementing high-content screens using models generated with patients-derived cells was celebrated by Gerardo Turcatti,Director OF Ecole Polytechnique
Fédérale de Lausanne (EPFL), in the Theater Room from CIMUS Building
PICTURES
More info: CIMUS Web
Published in Web (15/07/2022)
Lab Meeting Neila Cosme in the CIMUS building
8 July 2022
Lab Meeting was celebrated las 8 of July in the Theater Room (CIMUS building)
Published in Web (8/07/2022)
Lab Meeting Daniel López in the CIMUS building
1 July 2022
Lab Meeting "Young CSF restores oligodendrogenesis and memory in aged mice via Fgf17" celebrated in the Theater Room (CIMUS building)
More Info:
Published in Web (1/07/2022)
SEQT congress attendees visit the INNOPHARMA infrastructures
21 Junio 2022
On June 21st, attendees of the congress of the X national meeting of the Spanish Society of Medicinal Chemistry visited the INNOPHARMA infrastructures.
More info: SEQT Congress 2022
Published in Web (21/06/2022)
XX national meeting of the Spanish Society of Medicinal Chemistry
21 June 2022
Phd Mabel Loza(BioFarma Group Coordinator)
)
participated last 30st of September in the XX national meeting of the Spanish Society of Medicinal Chemistry that was celebrated last 21 of June in Santiago de Compostela.
More info:
Program
Published in Web (21/06/2022)
Marta Cimadevila Seminar: GLUGLU – the challenge of mGluR internalization
10th June 2022
Seminar in the Theater Room (CIMUS building)
More info: Web CIMUS
Published in Web (09/06/2022)
VIII Edition Biomedical Cancer Research Conference en A Coruña
2 June 2022
Phd Mabel Loza (BioFarma Group Coordinator) participated last 30st of September in the meeting: VIII Edition Biomedical Cancer Research Conference that was celebrated last 2nd of June in A
Coruña
More info:
See program
Published in Web (2/06/2022)
Professor Juan Tamargo in the CIMUS building
22nd April 2021
Professor Juan Tamargo participated last 22th April in the Debate con referentes, which was held in the CIMUS building and organised by the
Biofarma Group.
Program
More info:
CIMUS web
Published in Web (22/04/2022)
Lab Meeting Geert Daudey in the CIMUS Building
th8 April 2022
Lab Meeting celebrated in the Theater Room (CIMUS)
Published in Web (8/04/2022)
Lab Meeting Iria Brocos in CIMUS Building
18th February 2022
Lab Meeting "Del estudio de los receptores adrenérgicos a2 y la proteína espinofilina en la corteza prefrontal postmortem de sujetos con esquizofrenia a las colaboraciones externas" celebrated in the Theater Room (CIMUS building)
Published in Web (18/02/2022)
Actualización y ampliación de las capacidades científico-técnicas de la
Plataforma del partner site del ERIC EU-OPENSCREEN de la USC: Plataforma de cribado de fármacos y farmacogenómica INNOPHARMA del CiMUS
14 December 2021
Phd Mabel Loza (BioFarma Group Coordinator) participated last 30st of September in the meeting: "Actualización y ampliación de las capacidades científico-técnicas de la Plataforma del partner
site del ERIC EU-OPENSCREEN de la USC: Plataforma de cribado de fármacos y farmacogenómica INNOPHARMA del CiMUS"
More info:
https://www.usc.es/cimus/en/events/seminario-actualizacion-y-ampliacion-de-las-capacidades-cientifico-tecnicas-de-la-plataforma
Published in Web (15/12/2021)
Jornada Redtransfer: "Retos y oportunidades de la transferencia de conocimiento"
15th November 2021
Phd Mabel Loza (BioFarma Group Coordinator) and PhD Jose Brea
(Head of HTS in the Biofarma group) participated last 16th of November in Jornada Redtransfer: "Retos y oportunidades de la transferencia de conocimiento".
More info:
https://redtransfer.org/evento/jornada-redtransfer-retos-y-oportunidades-de-transferencia-de-conocimiento
See Program
Published in Web (17/11/2021)
Doctor Francisco Zaragozá in the CIMUS building
15 Noviembre 2021
Dr. Francisco Zaragozá participated last 19th November in the Debate con referentes, which was held in the CIMUS building and organised by the
Biofarma Group.
Program
More info:
Web del CIMUS
Published in Web (19/11/2021)
Autumn training school 2021 EU – OPENSCREEN
15th November 2021
Phd Mabel Loza (BioFarma Group Coordinator) and PhD Jose Brea
(Head of HTS in the Biofarma group) participated last 15th of Noviembre in Autumn training school 2021 EU – OPENSCREEN.
More info:
https://www.eu-openscreen.eu/services/training/autumn-training-school-2021.html
Published in Web (8/10/2021)
Australia - Europe Symposium on Research Infrastructures
5 Octubre 2021
Phd Mabel Loza (BioFarma Group Coordinator) participated last 30st of September in the meeting Australia - Europe Symposium on Research Infrastructures that was celebrated from 5 to 7
online.
More info:
https://ri-vis.eu/events/australia---europe-symposium-on-research-infrastructures/
See Agenda
Published in Web (8/10/2021)
Transferencia del conocimiento universitario desde una perspectiva de género.
30st September 2021
Phd Mabel Loza (BioFarma Group Coordinator) participated last 30st of September in the meeting Transferencia del conocimiento universitario desde una perspectiva de género that was celebrated online.
More info:https://www.transferenciaexenero.gal/es/inicio-es/
Published in Web (30/09/2021)
XIV Conferencia Anual de las Plataformas Tecnológicas de
Investigación Biomédica.
11th May 2021
The Biofarma Group Coordinator
Mabel Loza assited last 11th of March to the XIV Conferencia Anual de las Plataformas Tecnoló
gicas de Investigación Biomédica that was celebrated online. .
The Biofarma Group Coordinator
Mabel Loza assited last 10th of March to the meeting: jornada
informativa RIs en ciencias biomédicas that was celebrated online. .
PROGRAM
Published in Web (11/03/2021)
Antón Martínez participated in Compañía de María orientation Talk
9th March 2021
PhD Antón Martínez from BioFarma Group
participated last 9th of March with a orientation talk in Compañía de María School (Vigo) .
PICTURES
Published in Web (9/03/2021)
1st EU-OPENSCREEN Industry Liaison Office Virtual Meeting.
11st February 2021
Phd Mabel Loza (BioFarma Group Coordinator) participated last 11st of February in the meeting 1st EU-OPENSCREEN Industry Liaison Office Virtual Meeting that was celebrated online.
AGENDA
11:00 – 11:10 Welcome address and goal of the meeting Speaker: Prof. Kjetil Tasken, University of Osloz 11:10 – 11:20 EU-OPENSCREEN: European infrastructure of open screening platforms for chemical biology Speaker: Dr. Wolfgang Fecke, EU-OPENSCREEN ERIC 11:20 – 11:30 EU-OPENSCREEN: building innovation in drug discovery Speaker: Prof. Mabel Loza, University of Santiago de Compostela 11:30 – 11:40 High-throughput flow cytometry applied to immune phenotyping and cell signaling analysis comparing control and patient samples Speaker: Dr. Johannes Landskron, University of Osloz 11:40 – 12:30 Round table discussionz Moderators: Prof. Mabel Loza and Prof. Kjetil Tasken
-Introduction of industry participants
-Industry needs and interest in collaborating with EU-OPENSCREEN
-Industry contribution and access to EU-OPENSCREEN
-EU-OPENSCREEN development
Published in Web (11/02/2021)
Biotecnología y ciencias de la vida, apuestas para mejor futuro.
16th December 2020
Phd Mabel Loza (BioFarma Group Coordinator) participated last 16st of December from 9:30 to 10:30 in the Roundtable "Biotecnología y ciencias de la vida, apuestas para mejor futuro" that was celebrated online.
PROGRAM
Los días después del día después…
'Biotecnología y ciencias de la vida, apuestas para mejor futuro'
MÍERCOLES 16 DE DICIEMBRE, 9:30 horas
'Biotecnología y ciencias de la vida, apuestas para mejor futuro'
Desde que saltasen las alarmas frente a la amenaza del coronavirus en diciembre del 2019 en Wuhan, China, la comunidad biotecnológica no ha parado de aumentar sus esfuerzos y se ha volcado en estudiar el virus y en desarrollar diagnósticos, tratamientos y vacunas que ayuden a proteger a las personas frente al Covid-19.
Pero además de atender lo inmediato, debemos comenzar desde ya a trabajar en el futuro, centrando todos nuestros esfuerzos en poner las bases para intentar minimizar pandemias futuras. Y eso solo pasa por seguir incrementando los recursos en investigación en un sector, el biotecnológico, que es intensivo en conocimiento.
Hoy, más que nunca, el biotecnológico es un sector imprescindible, con un papel determinante en la búsqueda de tratamientos contra el Covid-19 o en la crisis climática. ¿Hacia dónde camina el sector biotecnológico gallego? ¿Qué peso le corresponderá en esta nueva economía que se está forjando?
En este encuentro online, compartiremos con Mabel Loza y Andrés Fernández sus experiencias durante esta situación, lo que se está haciendo y sobre todo lo que se debe hacer en el futuro.
PONENTES INVITADOS:
MABEL LOZA
Catedrática de Farmacología y responsable del grupo de investigación BIOFARMA de la Universidad de Santiago (USC).
ANDRÉS FERNÁNDEZ
CEO de GRUPO ZENDAL. MODERADOR-ENTREVISTADOR:
MANUEL REGO
Socio director de WIT Talento, presidente de Alumni IESIDE (Asociación de antiguos alumnos de IESIDE).
Entrevista a dos, planteada por Manuel Rego, presidente de Alumni IESIDE, a Andrés Fernández y Mabel Loza, CEO del Grupo Zendal y responsable del grupo de investigación BIOFARMA de la Universidad de Santiago (USC)., respectivamente.
El moderador-entrevistador planteara a los ponentes invitados una serie de cuestiones, dando paso a sus intervenciones.
Cuestiones:
- Las vacunas están llegando. ¿Cómo creen que se va a desarrollar el proceso de vacunación en España? ¿qué se necesita para producir tantas vacunas? ¿hace falta algo más?, ¿existe realmente capacidad de producción para suministro global? Se puede dar un mensaje/perspectiva de seguridad que ofrezca una tranquilidad económica que nos permita planificar el futuro inmediato del negocio y la actividad comercial e industrial
- En un mundo tan desarrollado, tecnológico y digital basado en el conocimiento, ¿cómo un virus puede ponernos en jaque? ¿cómo pasó? ¿por qué no estábamos preparados?
- Y a partir de ahora, en el futuro… ¿qué pasará? ¿aparecerán nuevos virus que nos pondrán en peligro nuevamente? ¿Cómo nos preparamos? Es posible que nos sintamos más débiles a partir de ahora ¿cómo recuperamos la confianza?
- ¿Hacia dónde camina el sector biotecnológico gallego? ¿Qué peso le corresponderá en esta nueva economía que se está forjando? Desde la perspectiva de la investigación y desde la de fabricación.
- ¿Cuáles son los principales desafíos de la biotecnología y ciencias de la vida para los próximos años? ¿Cuáles son los temas críticos que la comunidad esta intentando resolver, más allá del Covid-19?
- Hablamos de la necesidad de colaboración público-privada y colaboración entre la investigación y la industria para el desarrollo del sector ¿existe?, ¿es indispensable? ¿qué le demandaríais a las diferentes partes para que la colaboración fuese aún más efectiva?
- Es ineludible hablar de educación, ¿Cómo podemos incentivar la vocación de nuestros jóvenes por investigar? Y, no menos importante, ¿qué pasos hemos de dar en el mundo de la empresa para aprovechar ese talento que se nos está yendo fuera?
El moderador irá seleccionando algunas de las preguntas que haga el público durante la entrevista y realizará para concluir una o dos preguntas a los entrevistados.
Fecha: miércoles 16 de diciembre // Horario: 9:30 a 10:30 h.
Formato: Virtual – Plataforma web (en línea)
Published in Web (17/12/2020)
Elia Álvarez thesis defense.
2nd December 2020
Phd Elia Álvarez from Biofarma Group exposed last 2nd of December the thesis: Identificación de nuevos
ligandos dirigidos a la interleuquina 17 con utilidad farmacológica en enfermedades autoinmunes (online - Microsfot Teams).
PICTURES
Published in Web (3/12/2020)
Biotecnología y Ciencias de la vida. Del Desconocimiento (social) a la necesidad (colectiva).
28st October 2020
Phd Mabel Loza (BioFarma Group Coordinator) participated last 28st of October in the Roundtable "¿Apuesta Galicia por la biotecnología?'" that was celebrated in the meeting: Biotecnología y Ciencias de la vida. Del
Desconocimiento (social) a la necesidad (colectiva).
PICTURES
Published in Web (29/09/2020)
Mabel Loza´s Interview in Correo TV
29 September 2020
PhD Mabel Loza´s (Biofarma Group coordinator) interview in Querido Mundo (Correo TV)
Published in Web (29/09/2020)
Antón Martínez in IV International Virtual
Conference on Educational Research and Innovation
23-24 September 2020
PhD Antón Martínez, from
Biofarma Group, assisted to the IV International Virtual Conference on Educational Research and Innovation that was celebrated from
23 to 24 September online
PUBLICATIONS
Antón L. Martínez Rodríguez, Marián Castro Pérez, Ángel García Alonso, Ezequiel Álvarez
Castro, Jose Manuel Brea, Mabel Loza García Application of the Canvas Method to Learning in Drug Development
This paper will be published in a Book of Proceedings with ISBN 978-84-09-22966-6
Published in Web (25/09/2020)
Webinar "DNA-encoded libraries to identify novel chemical matter
for undruggable targets"
21st September 2020
Phd Mabel Loza (BioFarma Group Coordinator) participated last 21st of September in the Webinar "DNA-encoded libraries to identify novel chemical matter for undruggable targets" that was
celebrated online
Elia Álvarez and Laura Gómez participate in the
III Annual
CiMUS Workshop
20th July 2020
The predoctoral students Elia Álvarez and Laura Gómez from
BioFarma Group
participated last 20th of July in the III Annual CiMUS Workshop with the posters Intracellular crosstalk of the D2/5-HT2A heterodimer and IA Label-Free Platform for Assessing the
Ligandability of Protein-Protein Interaction Targets
Antón Martínez participated in III Annual CiMUS Workshop
20th July 2020
PhD Antón Martínez from BioFarma Group
participated last 20th of July in the III Annual CiMUS Workshop with the conference Development of a Neuronal Model to Discover Novel Targets for Neuropathic Pain (Martínez AL,
Goiricelaya E, Varela MJ, Cruz R, Brea J, Burgueño J, Merlos M, Carracedo A, Loza MI, Allegue C, Domínguez E).
PICTURES
Published in Web (20/07/2020)
Marta Cimadevila thesis defense
7th May 2020
The Postdoctoral Researcher Marta Cimadevila from BioFarma Group exposed last 7th of May the thesis: Estudio de la influencia de los puentes disulfuro extracelulares del receptor 5-HT2A homodimérico en la farmacología antipsicótica that was celebrated by videoconference.
Mabel Loza participated in "Universitarias, científicas y emprendedoras"
10th March 2020
PhD Mabel Loza from BioFarma Group
participated with Eva López Barrio, Mar Lorenzo and Carme Pampín in the Roundtable "Universitarias, científicas y emprendedoras" that was
celebrated last 10th of March in Ateneo de Santiago.
PhD Mabel Loza, BioFarma Group Coordinator, organized
from 16th to 19th of February the Congress Brain Therapeutics: Disruptive Technologies and Opportunities (Keystone Symposia) that was celebrated in El Dorado
Hotel (Santa Fe, United States).
Mabel Loza participated as speaker in the roundtable Collaboration & Knowledge Integration Models for Successful Brain Therapeutics with James E. Audia (Chicago Biomedical Consortium, USA), Chas Bountra (University of Oxford, UK) and Sohini Chowdury (Michael J. Fox Foundation, USA)
PhD Mabel LozaBioFarma Group Coordinator,
participated last 11th of February as speaker in the roundtable Mujer de Ciencia with Patricia Argerey (GAIN), María José Alonso (IP CiMUS Nanobiofar), Sara Campos (Ejecutivas
Galicia-Gradiant), Rocío Mosquera (AMIT-Gal), Ángel Carracedo (IP CiMUS Medicina Xenómica),Ruth González (CiMUS)and Susana López
Abella (Secretaria Xeral de Igualdade). The roundtable was celebrated in the CIMUS Building (Santiago de Compostela).
Mabel Loza participated in "Mulleres referentes na
ciencia en Galicia"
3rd February 2020
PhD Mabel Loza from BioFarma Group
participated as speaker in "Mulleres referentes na ciencia en Galicia", that was celebrated in Ourense last 3rd of February.
International Meeting: "N²: Networking between Networks
17th December 2019
Last 17th of December was celebrated the International Meeting "N2: Networking between Networks" in the CEA Building. Relevant actors of the academic and industry worlds came to Santiago to discuss and debate together about the dynamics and purposes of the interaction between collaborative
networks. The purpose was elaborate a fruitful debate, is to nurture and/or strengthen synergies in order to save the still existing gap(s) and challenges in
translational research transfer.
We believe that the "N2" event were a unique opportunity to connect and learn from each other, sharing different experiences coming from different networks. A great
opportunity to express our respective visions and goals, identify strategic steps and propose relevant actions accordingly.
Small Molecules in Plant Research: Chemistry and Biology Come Together
12th December 2019
Jose Brea PhD participated last 10 and 11 of December in The Symposium on Small Molecules in Plant Research: Chemistry and Biology Come Together with the speak: "EU-Chemical Biology Screening Platforms: an opportunity for Plant Research" .
BioFarma Group Coordinator Mabel Loza participated in
the 2° Feira da Innovación USC
29th November 2019
Mabel Loza PhD, (BioFarma Group Coordinator) participated last Thursday 29 of November in the 2° Feira da Innovación USC with the meeting: Fármacos: Innovar para curar. «Ayudar a la gente a tener una mejor calidad de vida: no hay mejor resumen de lo que significa innovar en el ámbito farmacológico«
PICTURES
Published in Web (29/11/2019)
BioFarma Group Coordinator Mabel Loza win Wonenburguer Prize
2019
10th October 2019
PhD Mabel Loza, (BioFarma Group Coordinator) win the Wonenburguer Prize 2019.
Professor of Pharmacology at the University of Santiago de Compostela. Head of BioFarma pharmacology research group at the University of Santiago de Compostela. Active
participation in the development of 14 NCE that have reached clinical trials in the specific programmes of R&D transfer in drug development of different pharmaceutical companies.
Leader in the field of Early Drug Discovery at Spanish and European levels, endorsed by the participation in more than 100 research programs, 89 of them as principal investigator, founded by
public and private institutions such as the Regional Galician Government, "La Marató de TV3" Foundation, the Spanish Government and the European Union (10 in total: TESEMED I and II,
INFOPHARMA, GALA, LINK3D, DIOMED (Sudoe Interreg programme), EU-ADR, CHAPRION (Horizon 2020) and Open PHACTS (IMI 7th Framework Program, that has been selected as one of the most successful IMI
programs for further continuation).
Pictures: El Correo Gallego (https://www.elcorreogallego.es/fotos/ecg/i-international-conference-and-workshop-microbiota-what-s-cookinga/idGaleria-11290)
The BioFarma group visited the International
Iberian Nanotechnology Laboratory in Braga
4th October 2019
The BioFarma Group participated last 4th of October in a meeting celebrated in the International
Iberian Nanotechnology Laboratory. PURPOSE: Visit to the INL in Braga (Portugal) to learn about the centre, its capabilities and facilities. In particular, more details about the lines of the research groups of the
Principal Investigators that were our hosts, with the view of collaborating in current or future international project calls.
PARTICIPANTES
INL
Lorena Diéguez, Group Leader, Medical Devices
Manuel Bañobre, Group Leader, Nanomedicine
(MB) Bruno Silva, Staff Researcher, Nanomedicine
BioFarma group
Eduardo Domínguez, PhD, BioFarma-USEF Research Group
Center for Research in Molecular Medicine and Chronic Diseases
(CIMUS) - USC
Genomic Medicine
Catarina Allegue,
Responsible of Genomic Editing and Transcriptomics, MXG
(CA) https://www.xenomica.eu/
CIMUS - USC
Mabel Loza assited to a Induction Week in the EMOTION
Master
23rd-27th September 2019
PhD Mabel Loza from BioFarma Group assisted from
23th to 27th of September to the Induction Week in the The European Master in Translational Cosmetic and Dermatological Sciences (EMOTION) that was celebrated in Novara.
The mission of EMOTION is to educate the future generation of translational scientists and professionals in dermocosmesis and dermatologic therapies and
to equip them with the skills and competences to work in R&D. To achieve this aim, the EMOTION consortium has been designed and structured to assemble an integrated group of
scientists/teachers/professionals with complementary expertise that covers the entire interdisciplinary field.
Location: Department of Pharmaceutical Sciences, Novara(Italy).
Mabel Loza member in the First European Purine Club Meeting 2019 commitee
4th-6th September 2019
PhD Mabel Loza from BioFarma Group participated as Comittee member in the First European Purine Club Meeting 2019 that was celebrated from 4th to 6th of Septiembre in Santiago de Compostela
Location: School of Medicine of the USC, Santiago de Compostela(Spain).
EU-OPENSCREEN offers 23 fully funded research projects in the areas of chemoproteomics, small molecule screening and medicinal chemistry.
Eligible proposals will be evaluated by external reviewers, and successful applicants will be selected in an open and transparent process.Transnational access comprises a total of 6
chemoproteomics, 12 small molecule screening and 5 medicinal chemistry projects. The European Commission only allows transnational access, meaning that users are not eligible to get access to a facility that is located in their home country.
Several members from BioFarma Group participated in the II Annual CiMUS Workshop that was celebrated last 12th of July in the
CIMUS Building (Santiago de Compostela).
PICTURES
Location: CIMUS Building, Santiago de Compostela (Spain).
Download program
Published in Web (15/07/2019)
Mabel Loza assisted to The 44Th FEBS Congress
12th July 2019
PhD Mabel Loza from BioFarma Group participated in The 44TH FEBS Congress
with the meeting: ES-OPENSCREEN: The Spanish open innovation ecosystem in chemical biology and drug discovery. The Congress was celebrated from 6th to 11th of July in Krakovia.
PICTURES
Location: CIMUS Building, Santiago de Compostela(España).
Download program
Published in Web (15/07/2019)
Pepo Brea in the seminar "Complementary technologies to deliver deeper insight in
drug discovery"
10th July 2019
PhD Pepo Brea from BioFarma Group participated last 10th of July in the commercial
seminar "Complementary technologies to deliver deeper insight in drug
discovery" that was celebrated by GE Gealthcare in collaboration with Innopharma.
BioFarma in the Spanish Society of Pharmacology Meeting
3rd-5th July 2019
The BioFarma Group assisted to the Spanish Society of Pharmacology Meeting that was celebrated
in Las Palmas (Reina Isabel Hotel) from 3rd to 5th of July.
AWARDS
Laura Gómez from BioFarma Group won the Best Poster Award.
Marta Cimadevila from BioFarma Group won the Award to Mention of the Best Oral Communication
PICTURES
Location: Reina Isabel Hotel, Las Palmas de Gran Canaria, Spain.
Published in Web (8/07/2019)
PhD Eduardo Domínguez assisted to the SLAS Europe 2019 in Barcelona
The Postdoctoral Researcher Andrea García from BioFarma Group exposed last 9th of May the thesis: Estudio de aspectos emergentes en la farmacología de receptores acoplados a proteínas G relevantes en esquizofrenia: alosterismo, selectividad funcional y compartimentación de la señalización in the Graduate Hall School of Pharmacy.
PICTURES
Location: Graduate Hall School of Pharmacy. Santiago de Compostela.
Published in Web (9/05/2019)
PhD Steve P Watson seminar
26th April 2019
PhD Steve P Watson (Professor in Cardiovascular Sciences and Cellular Pharmacology
at Institute of Cardiovascular Sciences and Cellular Pharmacology of University of Birmingham) celebrated last 26th of April at 13:00 the seminar "GPVI and CLEC-2 as targets for
a new class of anti-platelet drug in thrombosis and thromboinflammation" in the CIMUS Building.
Location: Theater Room, CIMUS Building, Santiago de Compostela.
Published in Web (29/04/2019)
The Predoctoral Student Marta Cimadevila won Best Poster Award in the ECBS2019
6th European Chemical Biology Symposium/ EUCHEMS-LS 2019 in Madrid
The ECBS 2019 in Madrid, Spain, brought together more than 200 scientists from the field of chemical biology, highlighting recent discoveries in screening and drug discovery, systems biology and therapeutic innovation. Chemical biologists from all parts of Europe and overseas came together to present and discuss the latest achievements in organic & biological chemistry, proteins biotechnology, computational biology, proto-cells, machine learning, bacterial resistance, drug discovery, synthetic biology, biomedical materials and chemical glycobiology.
Highlight talks were given by international experts in the field of chemical biology: Stephen Mann (University of Bristol, UK), Anne Imberty (CNRS, FR), Modesto Orozco (IRB Barcelona, ES), Giuseppe Battaglia (University College of London, UK), Cynthia J. Burros (University of Utah, USA) and Federico Gago (University of Alcalá, ES). Representatives from EU-OPENSCREEN partner sites gave illuminating talks on their work: Jacek Kolanowski (IBCH-PAS, PL), Bernhard Ellinger (Fraunhofer IME, DE), Francisca Vicente (MEDINA, ES), José Brea (USC-Innopharma, ES), Luca Laraia (DTU, DK), TorkildVisnes (SINTEF, NO) and Marc Nazaré (FMP-FVB). Bahne Stechmann and Katja Herzog from the EU-OPENSCREEN ERIC team presented access models for EU-OPENSCREEN users in a talk and poster session. Source: EU-OPENSCREEN Newsletter
Jornada Internacional de Enfermedades Raras: Ciliopatías Comunes y Ultrararas
29th March 2019
The BioFarma Group participated last 29th of March at 12:40 in the Jornada Internacional de Enfermedades Raras: Ciliopatías Comunes y Ultrararas
with the meeting: Orphan drug development in rare diseases: from research and innovation to patients.
Location: Auditorio Marie Curie, UVigo-Ourense Campus da Auga.
More Info
Published in Web (29/03/2019)
XII Conferencia Anual de las plataformas tecnológicas de investigación
médica
6th March 2019
Mabel Loza PhD from BioFarma Group participated last 6th of March in the Round Table:
Financiación de Iniciativas para atraer investigación biomédica a España (II) with the meeting Financiación para la constitución de un hub en descubrimiento
de fármacos en Galicia.
Dr Francesc Artigas (IIBB – CSIC) and Dr. Umberto Spampinato (University of Bordeaux) visited last Monday 25th of February the Innopharma facilities in the
CIMUS Building, they spoke about: "Role of prefrontal 5-HT2A receptors in psychosis" (Dr. Francesc Artigas) "The central serotonin2B receptor & dopamine ascending pathways: new opportunities for the treatment of schizophrenia" (Dr. Umberto Spampinato)
PICTURES
Location: Theater Room, CIMUS Building. Santiago de Compostela.
Published in Web (15/02/2019)
Joaquín Dopazo Seminar: La larga vida del dato genómico. Uso y
reutilización dentro del sistema de salud
31st January 2019
Dr. Joaquín Dopazo
(Head of the Bioinformatics group, CIBERER) spoke about La larga vida del dato genómico. Uso y reutilización dentro del sistema de salud last thursday 31st of January at 12:30 in the seminar
organized by REGID. Dr. Joaquin Dopazo is the Head of the Clinical Bioinformatics Area, FPS, Sevilla, Spain. He has a BSc in Chemistry and a PhD in Biology (Universitat de Valencia, 1989). He was previously leading Bioinformatics teams at the CNIO (Madrid, Spain) and Glaxo Wellcome (Madrid, Spain), as well as in some other private and academic institutions. He has published more than 270 papers in international
peer-reviewed journals. His interests revolve around functional genomics, genome analysis and systems biology with special stress on clinic and traslational applications. Dr. Dopazo has supervised some
of the largest and most cited resources for genomic data analysis over the web (
https://www.babelomics.org).
The Postdoctoral Researcher Antón Martínez from Biofarma Group exposed last 18th of December the thesis: Desarrollo de modelos
in vitro de dolor y su aplicación al cribado de alto rendimiento in the Graduate Hall School of Pharmacy.
PICTURES
Location: Graduate Hall School of Pharmacy. Santiago de Compostela.
The Postdoctoral Researcher Alejandro González from Biofarma Group exposed last 30th of November the thesis: Identificación de
nuevos compuestos activos en el receptor GPR35. Un receptor huérfano implicado en procesos inflamatorios in the Graduate Hall School of Pharmacy.
PICTURES
Location: Graduate Hall School of Pharmacy. Santiago de Compostela.
Published in Web (3/12/2018)
PhD Mabel Loza received the innovative award prize in Madrid
29th November 2018
PhD Mabel Loza, from Biofarma Group, received last thursday 28th of November the Innovative Researcher 2018 award in the FEI
Recognitions celebrated in Madrid.
PICTURES
Location: Aula C de la Escuela Técnica Superior de Ingenieros Industriales. Madrid.
PhD Iria Gómez in the I Feira da Innovación USC-ABANCA
27th November 2018
PhD Iria Gómez, from Biofarma Group, spoke about: "Cómo pedir bolsas e non desesperar no intento" in the I Feira da Innovación
USC-ABANCA celebrated last 27th of November in Santiago de Compostela.
PICTURES
Location: Ciudad de la Cultura. Santiago de Compostela.
PhD Marta Piñeiro and PhD María Jesús Blanco Conference
22nd November 2018
Marta Piñeiro (Chief Of Staff - Small Molecule R&D, Indianapolis) and
María Jesús Blanco (Director of Medicinal Chemistry at SAGE, Boston) participated last 22nd of
November in the conference: "Testimonios de Mujeres Científicas y Empresarias" in the Graduate Hall School of Pharmacy.
Location:Graduate Hall School of Pharmacy. Santiago de Compostela.
Published in Web (22/11/2018)
PhD Parth Chakrabarti Seminar
22nd November 2018
Parth Chakrabarti (Global Head of Business Development- Immunology at Sanofi Genzyme based in Boston, USA) spoke last 22nd of
November about: "Business of Innovation in Healthcare" in the Theater Room from the CIMUS Building.
PICTURES
Location: Theater Room. CIMUS Building.
Published in Web (22/11/2018)
PhD Itziar Alcorta seminar
24th October 2018
PhD Itziar Alkorta, Biochemistry Associate Professor at University of Basque Country spoke last
17th of October about: Resistencia a antibióticos, una visión One Health in the Aulario Novoa Santos.
PICTURES
Location: Aula 10. Aulario Novoa Santos. Edificio Docente Roberto Novoa Santos (Trva. de la Choupana, s/n).
Published in Web (17/10/2018)
PhD Iria Gomez seminar
17th October 2018
Phd Iria Gómez from Biofarma Group organized a seminar to speak about: "La importancia de
conocer los mecanismos de autorreactividad para el diseño de inmunoterapias más efectivas", that
was celebrated last 17th of October in The CIMUS Building.
PICTURES
Location: Theater Room, CIMUS Building.
Published in Web (17/10/2018)
Colorectal cancer: from immune modulation to metastatic signaling pathways
16th October 2018
Phd Klaus-Peter Janssen, Technische Universität München | TUM, Clinic and Polyclinic for Surgery
(Germany) spoke last 16th of October about: "Colorectal cancer: from immune modulation to metastatic signaling pathways" in the CIMUS Building.
Phd Mabel Loza (chair in a session) and
PhD Eduardo Domínguez from Biofarma
Group assisted to the V edition Biomedical Cancer Reseach Conference, that was celebrated last 4th of October in A Coruña.
BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of
one-to-one meetings (+3.000) and companies participating (+800). 34% of our delegates came from outside of Spain.
Why Spain?
In 2015 there were 2,981 enterprises engaged in biotechnology related activities in Spain (+8.72% compared to 2014), of which 654 are dedicated
biotechnology enterprises (+4.17%), according to data in the ASEBIO Report 2016.
The number of people directly employed by the biotechnology sector reached 182,156 (+2.35%). The turnover of dedicated biotechnology enterprises totalled €8.2 billion in 2015, with growth reaching
7.38%.
Internal spending on biotechnology R&D reached €578 million (+8.31), regaining some of the the growth lost over recent years, according to INE data for 2015.
Published in Web (29/09/2018)
Horizon Europe Santander 2018 in the UIMP
10th September 2018
PhD Mabel Loza participated last 10th of September in Horizon Europe Santander 2018, celebrated in the
Menéndez Pelayo International University
Location: Menéndez Pelayo International University. Santander.
Published in Web (11/09/2018)
Biofarma Workshop:"Patterns of Membrane Protein Clustering (MPC) as a
biomarker of mental disorder"
4th September 2018
The Biofarma Group organized last 4th of September the workshop:
"Patterns of Membrane Protein Clustering (MPC) as a biomarker of mental disorder" that was celebrated in the CIMUS Building. Location: Theater Room, CIMUS Building. Santiago de Compostela.
Héctor Caruncho conference: "Del laboratorio a la clínica y de nuevo al laboratorio".
17th July 2018
Hector caruncho PhD (Researcher in the University of Victoria) spoke last 17th of July
at 12:00 A.M. about "Del laboratorio a la clínica y de nuevo al laboratorio".
Location: Theater Room, Cimus Building
PICTURES
Published in Web (17/07/2018)
1st Meeting in Translational Pharmacology
19th - 22nd June 2018
From 19th to 22nd of June was celebrated in the Hotel Oca Puerta del Caminofrom Santiago de Compostela the 1st Meeting in Translational Pharmacology, 38th Spanish Society of Pharmacology meeting/9th Spanish Society of
Pharmacogenetics and Pharmacogenomics meeting.
Location: Hotel Oca Puerta del Camino, Santiago de Compostela.
Drug discovery processes have experienced a dramatic change in the last years moving from in-house programs to the Open Innovation paradigm where public-private partnerships are being stablished looking for more efficient processes. Thus, there is a new place for pharmacology in the global Open Innovation framework playing a new key role to leap over the gap from basic transformational science to real therapeutic solutions.
Within this open innovation framework and focusing in the translation of pharmacological results the meeting will focus in Translational Pharmacology, being a joint meeting of the Spanish Pharmacological Society and the Spanish Pharmacogenomics and Pharmacogenetics Society
Furthermore the Helenic, Italian and Portuguese pharmacological societies are going to participate as invited societies being a good opportunity for identifying future collaborations and partnerships.
The program includes plenary lectures, roundtables and poster sessions for sharing and discussing the novel advances in our disciplines. We also want to offer a networking environment for young researchers, thus those communications selected by the scientific committee will be presented as short communications in the main roundtables.
(Retrieved from SEF2018 web)
PICTURES
See more pictures
PRESS RELEASES
Published in Web (02/07/2018)
Estudio de homodímeros del receptor 5-HT2A de serotonina y sus mecanismos de activación en la farmacología de la esquizofrenia
16th March 2018
The Postdoctoral Researcher Alba Iglesias from Biofarma Group exposed last 16th of March
the thesis: Estudio de homodímeros del receptor 5-HT2A de serotonina y sus mecanismos de activación en la farmacología de la esquizofrenia. in the Graduate Hall School of
Pharmacy.
Location: Graduate Hall School of Pharmacy, Santiago de Compostela.
IMAGES
Published en Web (17/03/2018)
XI Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica: Medicamentos Innovadores, Nanomedicina, Tecnología Sanitaria y Mercados Biotecnológicos
Biofarma Group assit to the
Encontro UMIX that was celebrated last 13th of November in the City of Culture (Santiago de Compostela) to make a presentation of the Esteve Research Centre in collaboration
with the Biofarma Group.
Location: Salón de convencións do Edificio CINC. Cidade da Cultura. Santiago de Compostela
Published in Web (9/11/2017)
II Conferencia H2020 y Salud
8th November 2017
Mabel Loza PhD from
Biofarma Group participated in the event: II Conferencia H2020 y Salud that was celebrated last 8th of November in Madrid.
Location: Pabellón Ernest Lluch, Instituto de Salud Carlos III, c/ Monforte de Lemos, 5 – Madrid
Manuel Merlos: Sigma-1 receptor antagonists: a new target for the
treatment of pain
17th October 2017
Manuel Merlos PhD
, Director of
Pharmacology in Esteve Labs spoke about: Sigma-1 receptor antagonists: a new target for the treatment of pain
in a meeting celebrated last 17th of October in the CIMUS Building.
Location: Theater Room, CIMUS Building, Santiago de Compostela.
PICTURES
Published in Web (15/09/2017)
VII Xornada de Informática Xudicial e Delitos Informáticos
Date: 3rd October 2017. 12:30 Kristoff Van Emelen (CSO Product Development at ProDigest - Intestinal Research) spoke about:
The human microbiome: fad or new modality? last 3th of October in the CIMUS Building in Santiago de Compostela.
Location: Theatre Room, CIMUS Building; Santiago de Compostela
37th National Meeting of the Spanish Society of Pharmacology (SEF)
21st June 2017
From 18th to 21th of June was celebrated in Barcelona (Alimara Hotel) the
37th National Meeting of the Spanish Society of Pharmacology (SEF).
The researcher group Biofarma had a strong presence in the meeting. Mabel Loza, coordinator of the group, speaks about "Pharmacology leaping over the gap: bringing transformational mechanisms to drug discovery".
Innovative partnerships for medicines research: how is the landscape evolving?
13th June 2017
Sonia Gómez Fernández
from Biofarma Group exposed last 13th of June the tesis: Estudio In Vitro de la influencia del heterodímero de los receptores D2 de Dopamina y 5-HT2A de Serotonina. Aplicación a la Farmacoterapia Antipsicópita.
Location: Graduate Hall School of Pharmacy.
Visit Rebeca Grynspan; Ibero-American Secretary General
1st June 2017
Rebeca Grynspan, Ibero-American Secretary General, and the Council of EducationRomán Rodríguez, visited last 1st of June the Biofarma installations and the
CIMUS Building.
Location: CIMUS Building (Santiago de Compostela).
Graduados (licenciatura o grado en Ciencias experimentales y de la Salud) que
cumplan el requisito de estar matriculados en un máster de la USC en el curso 2016-2017; o bien, Graduados de Farmacia, Veterinaria o Medicina que estén matriculados en
primer curso de un programa de doctorado USC. en el curso 2016-2017.
Nota media igual o superior a 6 en el grado previo.
Garry Pairaudeau: Receptor kinetics vs CNS exposure: which is more important for a ghrelin inverse agonist
5th April 2017
PhD Garry Pairaudeau, Head of External Sciences at AstraZeneca spoke about: Receptor kinetics vs CNS exposure: which is more important for a ghrelin inverse agonist
last 5th of Abril in Santiago de Compostela.
Location: CIMUS Building, Theatre Room (Santiago de Compostela)
PICTURES
Published in Web (31/03/2017)
Piero Crespo Baraja: Nuevos conceptos para antitumorales dirigidos a la ruta RAS-ERK
Marta Piñeiro: Treinta años de Ciencia desde una perspectiva personal: de A Coruña A Indianápolis
27th March 2017
PhD Marta Piñeiro Nuñez from Eli Lilly and company spoke last 27th of March about Treinta años de Ciencia desde una perspectiva personal: de A Coruña A Indianápolis in Santiago de
Compostela. Location: Hospital de San Roque, rúa San Roque nº 2 (Santiago de Compostela)
PICTURES
Published in Web (28/03/2017)
BIO-Europe Spring Barcelona 2017
20th March 2017
The Biofarma Group participated in
BIO-Europe Spring Barcelona 2017 that was celebrated next 20th of March in Barcelona.
Location: Centro de Convenciones Internacional de Barcelona - CCiB (Barcelona, España)
La Vanguardia 22/03/2017
Published in Web (14/02/2017)
X Conferencia Anual de la Plataforma Tecnológica de Investigación Biomédica
Javier González Maeso: NF-kB and its epigenetic role in schizophrenia treatment
27th February 2017
Javier González Maeso PhD (Department of Physiology and Biophysics. Virginia
Commonwealth University. School of Medicine. Richmond, Virginia, USA)
spoke last 27th of February about: "NF-kB and its epigenetic role in schizophrenia treatment"
in the Cimus Building.
Location: Theater Room, Cimus Building.
PICTURES
Published in Web (17/02/2017)
Professor Chas Bountra: Patients desperately need new medicines. What are we doing about it?
24th February 2017
Professor Chas Bountra (Professor of Translational Medicine, Head of
Structural Genomics Consortium, Group Head / PI, Member of congregation and Unit Director Nuffield Department of Medicine. Medical Sciences Division. University of Oxford.)
spoke last 24th of February about: "Patients desperately need new medicines. What are we doing about it?"
in the Cimus Building.
Location: Theater Room, Cimus Building.
Published in Web (29/01/2017)
Pedro Miguel Echenique: La sublime utilidad de la ciencia inútil
2nd February 2017
Last 2nd February was celebrated an Event to certificate Specific Centres; Among them are the CIMUS Research Centre.
The President of the Xunta de Galicia assisted to the event. With regard to the location, it was celebrated in A Cidade da Cultura and contained two parts:
1- Conference of Pedro Miguel Echenique, "La sublime utilidad de la ciencia inútil"
(17:30)
2- Plaques Presentation Ceremony.(18:30)
Location: Cidade da Cultura, Santiago de Compostela.
Elia Álvarez Coiradas received the award Fin de Carreira.
23th November 2016
Our Predoctoral Student Elia Álvarez Coiradas from Biofarma Group
received last 23th of November the award Fin de Carreira to the best transcript in Galicia
Last 3rd and 4th of November was celebrated in Santiago de Compostela (The City of Culture) the
VIII Spanish Discovery
Network Meeting, a forum that met drugs researchers to discuss about the vanguard in
the Chemichal Quemistry, the discovery of new drugs and the translational medical research.
The researcher group Biofarma had a strong presence in the meeting. Mabel Loza,
coordinator of the group,
participates in the scientist committee and emphasized the importance of that meeting. Angel Carracedo, Innopharma Coordinator with Mabel Loza, was one of the moderators in the seminars.
The VII Spanish Drug Discovery Networs Meeting finished with a visit to Biofarma infrastructure Marta Cimadevila, Alba Iglesias and
Alejandro González from
Biofarma Group participated in the meeting.
The Biofarma Group assisted to the Hamamatsu Live-Demo: Axiogenesis iPSC-derived Cells on the FDSSµCell
that was celebrated last 2nd November in CIMUS Building.
Location: Theater Room and Innopharma Labs, CIMUS Building, Santiago de Compostela.
Ailim Thesis: Estudio del impacto de la dimerización y de variantes polimórficas en la farmacología y
función de receptores acoplados a proteínas G (GPCRs) relevantes en esquizofrenia.
14th October 2016
Rocío Ailim de La Fuente PhD
from Biofarma Group exposed last 14th of October the tesis:: Estudio del impacto de la dimerización y de variantes polimórficas en la farmacología y
función de receptores acoplados a proteínas G (GPCRs) relevantes en esquizofrenia that was celebrated in The School of Pharmacy.
Location: Graduate Hall School of Pharmacy.
Health Councillor visit the Esteve Research Centre
20th Septiember 2016
Last 20th of September, Jesús Vázquez Almuíña, Health Councillor in Galicia, visited the
Esteve Research Centre, placed in the CIMUS Building (Santiago de Compostela). They collaborate with the Biofarma Group and
the University of Santiago de Compostela (USC). Location: CIMUS Building - Santiago de Compostela.
New Releases
Published in Web (21/09/2016)
Paula Vélez Thesis: Identificación de nuevos biomarcadores y dianas farmacológicas anti-plaquetarias
en infarto agudo de miocardio
19th September 2016
Paula Vélez from Biofarma Group exposed last 19th of September the tesis: Identificación de nuevos biomarcadores y dianas farmacológicas anti-plaquetarias en infarto agudo de miocardio
It was celebrated in the Graduate Hall School of Pharmacy.
Location: Graduate Hall School of Pharmacy (Santiago de Compostela).
Published in Web (16/09/2016)
5th International on Symposium DNA-encoded chemical libraries
Innopharma has been selected as a winner of 2015 Discovery Fast Track Challenge
19th July 2016
Innopharma group has been selected as a winner of 2015 Discovery Fast Track Challenge
. It was posted by GSK last 4th of March:
"GSK has announced the winners of its third Discovery Fast Track Challenge. The programme is sponsored by GSK's Discovery Partnerships with Academia (DPAc) group
to provide an opportunity for academic researchers in Europe and North America to collaborate with GSK and explore novel ideas for potential medicines. Six winning proposals were
selected from 378 entries submitted from 21 countries across Europe and North America. The selected proposals cover research related to discovery of potential new treatments for
cancer, inflammatory bowel disease, HIV and kidney disease."
María Jesús Blanco: Discovery of novel EP4 Antagonists: from screening to the clinic
5th July 2016
María Jesús Blanco PhD, Director Discovery Chemistry Research & Technologies. Eli
Lilly and Company, spoke about:
Discovery of novel EP4 Antagonists: from screening to the clinic in The
Theater Room. Location: Theatre Room, CIMUS Building.
Maribel Cadavid: Dimensiones y Características del Incumplimiento Terapéutico
1st June 2016
Maribel Cadavid PhD, from Biofarma
Group, spoke in the session: "Incumplimiento terapéutico: Un problema sanitario" about:
"Dimensiones y Características del Incumplimiento Terapéutico" in Santiago de Compostela. Location: Antiguo Hospital de San Roque, San Roque Street 2..
Workshop Innopharma: Conclusions and next steps in the Advanced Studies Center
10nd March 2016
Innopharma, The Galician platform for early drug discovery, celebrated last 10th and 11th march the
Workshop: Conclusions and next steps in the Advanced Studies Center in Santiago de Compostela.
A discussion forum where they have released the sustainability of the projects and the next steps in the pharmacogenomics platform Innopharma from USC, coordinated by PhD Angel Carrecedo and
PhD Mabel Loza.
The innovative public procurements, public- private collaboration, reverse knowledge transfer in the context of open innovation and the funding
opportunities in early stages form drug discovery were the most important issues in the working sessions.
Press Plubications:
Diario Médico
El Correo Gallego
La Voz de Galicia
Noticierio Galego
V Television
Published in Web (11/03/2016)
HIX Conferencia Anual de las Plataformas Tecnológicas de Investigación
Biomédica: Medicamentos Innovadores, Nanomedicina, Tecnología Sanitaria y Mercados Biotecnológicos
A project with the collaboration of Innopharma has benn selected by The
Fast Track Program Discovery.
4th March 2016
The Fast Track Program Discovery fom GSK company has selected among the winning projects in 2015 a project with the
collaboration of Innopharma USC and the National Center of Biotechnology (CNB-CSIC).
That is one of the six winning entries, chosen from among 378 projects from 21 countries in Europe and North America.
The research focuses in the develoment of an inmunnity program against the cancer applied to patient stratification.
The objective of the Discovery Fast Track Challenge is to accelerate the translation of development research in labs to the treatment of new therapies. PhDs
Angel Carracedo and Mabel Loza from Innopharma, and Isabel Mérida from CNB-CSIC, will collaborate with the scientific team of GSK´s Discovery Partnerships with Academy program
(DPAc) to screen the GSK library compounds against specific targets. The active compounds could form the bases for a complete discovery program drugs that could lead to the
discovery of innovate medicines against cancer.
Press Plubications:
La Voz de Galicia
Faro de Vigo
El Correo Gallego
El Economista
V Television
Xornada de presentación Programa Proba Concepto (Programa IGNICIA)
Linking Life Science Data: Desing to Implementation, and Beyond
5th February 2016
Sonia Lage Abad PhD from Biofarma Group,
exposed last 5th of February the tesis: "Estudio de la influencia de la reelina sobre receptores acoplados a proteínas G relacionadas con la farmacología de la
esquizofrenia" in CIMUS Building.
Location: Theatre Room, Cimus Building (Santiago de Compostela)
Pictures:
Published in Web (06/05/2016)
Cristina Val Thesis: Estrategias multicomponente en el descubrimiento de
derivados Heterocíclicos Antagonistas de los receptores de Adenosina/Inhibidores de Fosfodiesterasas
4th February 2016
Cristina Val García PhD from Biofarma Group,
exposed last 4th of February the tesis: "Estrategias multicomponente en el descubrimiento de derivados Heterocíclicos Antagonistas de los receptores de
Adenosina/Inhibidores de Fosfodiesterasas" in Graduate Hall School of Pharmacy.
Location: Graduate Hall School of Pharmacy (Santiago de Compostela)
Pictures:
Published in Web (05/02/2016)
Javier Carracedo Thesis: Aspectos estructurales y cinéticos de la
interacción ligando-receptor relevantes en la farmacología de la esquizofrenia
1st February 2016
Javier Rodriguez Carracedo PhD from Biofarma Group,
exposed last 1st of February the tesis: "Aspectos estructurales y cinéticos de la interacción ligando-receptor relevantes en la
farmacología de la esquizofrenia" in CIMUS Building
Location: Theatre Room, Cimus Building (Santiago de Compostela)
Pictures:
Published in Web (2/02/2016)
Elia Álvarez received the Antonio Casares Award
27st January 2016
The student Elia Álvarez Coiradas from Biofarma Group,
received last Wednesday 27th of January the Antonio Casares Award
from the Real Academia de Farmacia de Galicia Location: Antigo Hospital de San Roque, Santiago de Compostela
Begoña Roibás,
participated in the presentation: Un nuevo tiempo para Cotec that was celebrated in Madrid.
Location: Galería de Cristal del Palacio de Cibeles, Madrid, Spain.
Published en Web (24/11/2015)
II Workshop Innopharma
18th November 2015
Last wednesday 18th November, the Biofarma Group, participated in: II Workshop Innopharma that was celebrated in Santiago de Compostela.
Location: Hostal de Los Reyes Católicos, Santiago de Compostela.
Uxía Nogueira Recalde received the award Honorific Mention to the Best Oral Expresion
24th September 2015
The predoctoral student Uxía Nogueira Recalde , from Biofarma Group,
received the award: Honorific Mention to the Best Oral Expresion by her participation in the meeting Identification of Novel Molecules Targeting
Cartilage Aging as Osteoarthritis Therapeutics in the 36 Congreso de la Sociedad Española de Farmacología celebrated in Valencia
last 16th, 17th and 18th September.
The Biofarma Group, participated in: 36 Meeting Sociedad Española de Farmacología that was celebrated in Valencia. Location: Faculty of Medicine, University of Valencia.
Last wednesday 22nd July, the Biofarma Group, participated in: BioSpeed Dating that was celebrated in the CIMUS Building in Santiago de Compostela.
Location: CIMUS Building, Santiago de Compostela.
Conference Dr. Ivan Cornella (Merk Research Laboratories)
3rd July 2015
Dr. Ivan Cornella, Principal Scientist, Chemistry Capabilities Enhancement-Chemical Biology Lead at Merck Research Laboratories (Boston, USA) spoke about The Quest for New Targets. A Novel Early Discovery Model at Merck last 3rd July at 13:15 .
Location: Theater Room, CiMUS Building.
The Biofarma Group participated in: Meeting CIMUS - CIQUS that was celebrated in the Biology University of Santiago de Compostela.
Location: University of Santiago de Compostela.
2nd Open PHACTS Workshop “Understanding the knowledge management needs of phenotypic screening"
16th February 2015
The Biofarma Group organizated: 2nd Open PHACTS Workshop “Understanding the knowledge management needs of phenotypic screening" Location: Centro de Estudios Avanzados y Edificio CIMUS (Santiago de Compostela).
Jorge Barbazan: Cancer cells on the move! Circulating Tumor Cells in
metastatic dissemination
13th December 2014
Jorge Barbazan, PhD from Translational Medical Oncology Lab, Fundación Ramón Domínguez/IDIS.
Conference: “Cancer cells on the move! Circulating Tumor Cells in metastatic dissemination”. Location: Santiago de Compostela.
Published en Web (14/12/2014)
El grupo BioFarma de la USC y ESTEVE establecen su Unidad Mixta con el
objetivo de desarrollar fármacos contra el dolor
8ª Conferencia del Programa de Investigación e Innovación de la Unión Europea en España: Horizonte 2020
15th November 2014
Daniel Torrecilla PhD participated in: 8ª Conferencia del Programa de Investigación e Innovación de la Unión Europea en España: Horizonte 2020 - Primeras Experiencias y
Resultados. Location: Palacio de Exposiciones y Congresos, La Coruña.
Published en Web (1/12/2014)
Energy homeostasis and metabolic disease
7th November 2014
Eduardo Domínguez PhD participated in: Energy homeostasis and metabolic disease. Location: CNIC (Madrid).
article about Innopharma in The European Biotechnology Book
7th October 2014
The European Biotechnology Book has published an article about Innopharma.
"The book will consist of segments devoted to selected countries.
Each segment will showcase those who are leading in economic and cluster development, R&D, and will include a small number of companies invited to participate because
of their innovative pipelines or the fact that they are new to the biotechnology scene".
Andrea García Silva has been awarded with one of the five EPHAR (European Federation of
Pharmacological Societies) fellowships for young scientists
14th July 2014
AWARD
Our postgraduate student at the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS) Andrea García Silva has been awarded with
one of the five EPHAR (European Federation of Pharmacological Societies) fellowships for young scientists to attend the 2014 International Summer School
“DOPAMINE” within the International PhD Program in Neuropharmacology of the University of Catania, Italy.
Published en Web (14/07/2014)
Angelo Carotti: Multitarget Ligand as Potential Therapeutics in Neurodegenerative Disorders
10th July 2014
Angelo Carotti PhD. University of Bali (Italy).
Conference: "Multitarget Ligand as Potential Therapeutics in Neurodegenerative Disorders". Location: CIMUS Building (Santiago de Compostela).
The BIO International Convention; the global event of Biotechnology
23th June 2014
Eduardo Domínguez PhD and Mabel Loza PhD participated in: The BIO International Convention; the global event of Biotechnology Location: San Diego, (United States).
Mabel Loza PhD participated in: 7th Open Phacts Community Workshop "The 7th Open PHACTS Steering Committee Meeting was held at in Vienna on. The Steering Committee and Scientific
Advisory Board were informed about the great progress the project has made since it's start and were introduced to the future plans of the project. The Scientific Advisory Board was
very satisfied with the progress achieved and could provide very valuable advice on next steps."
From in vitro to in vivo molecular interaction studies using Perkin
Elmer Technologies
26th March 2014
Jose Brea PhD participated as speaker in the seminar: "From in vitro to in vivo molecular interaction studies using Perkin Elmer Technologies" Location: Centro Nacional de Investigaciones Oncológicas (Madrid).
Published en Web (13/03/2014)
The Biomedical Research about Cancer in Galicia
13th March 2014
Mabel Loza PhD participated in the conference: "The Biomedical Research about Cancer in Galicia" Location: Meeting Room, A Coruña Hospital (A Coruña).
VII Conferencia Anual de Plataformas Tecnológicas de
Investigación Biomédica
4th March 2014
Mabel Loza PhD and Jose Brea PhD
participated in the meeting: VII Conferencia Anual de Plataformas Tecnológicas de Investigación Biomédica: Medicamentos Innovadores, Nanomedicina, Teconologí
a Sanitaria y Mercados Biotecnológicos Date: Fira Palace Hotel in Barcelona (Barcelona).
The structure and objectives of H2020 was presented in the new program
of R&D for 2014-2020 period
3rd February 2014
The Biofarma Group participated in the presentation: The structure and objectives of H2020 was presented in the new program of R&D for 2014-2020 period, Location: Complexo Hospitalario Universitario de Santiago de Compostela (Santiago de Compostela).
Mabel Loza PhD participated in
XVII Semana Científica Antonio González Location: La Laguna University (Tenerife).
Published en Web (8/10/2013)
Antón Martínez received the award end of his college career
3th October 2013
AWARD
Date:3rd October. Antón Leandro Martínez from Biofarma Group received the award end of his college career of the autonomous community of Galicia
comunity .
Published en Web (3/10/2013)
INNOPHARMA presentation
2nd October 2013
Mabel Loza PhD and Ángel Carracedo PhD participated in the INNOPHARMA
presentation.
An opportunity for collaboration and valorisation in research for drug development. Location: Auditorium CIMUS (Santiago de Compostela).
Published en Web (25/09/2013)
Transbio Emergence Forum
25th September 2013
Jose Brea PhD participated in: Transbio Emergence Forum
Setting up collaborative projects on Molecular Medicine & Agrofood Innovation Location: Montpellier (France).
Published en Web (23/09/2013)
Patricio Atanes won an Award to Best Oral Communication at XXXIV Congreso de la Sociedad Española de
Farmacología
23th September 2013
AWARD
We are happy to announce that Patricio Atanes Juiz, a postdoctoral research of Biofarma's Group, has won an Award to Best Oral Communication
at XXXIV Congreso de la Sociedad Española de Farmacología for "The arylpiperazine derivatives LP-211 and MEL-9 are inactivating antagonists at human serotonin 5-HT7 receptors"
Published en Web (23/09/2013)
XXXIV Congreso de la Sociedad Española de Farmacología
16th September 2013
Biofarma Group participated in XXXIV Congreso de la Sociedad Española de Farmacología Location: San Pedro del Pinatar (Murcia).
Published en Web (16/09/2013)
Dr. Francisco Ciruela: Oligomerización de receptores acoplados a proteína G: Nuevos retos para el
tratamiento de enfermedades neurodegenerativas
30th July 2013
Dr. Francisco Ciruela Alférez
Seminar: Oligomerización de receptores acoplados a proteína G: Nuevos retos para el tratamiento de enfermedades neurodegenerativas.
Published en Web (26/07/2013)
Patricio Atanes Thesis: Estudio de la funcionalidad de GPCRs mediante el uso de herramientas
biológicas y químicas: aplicación a los receptores 5-HT2A y 5-HT7 de serotonina
30th July 2013
THESIS DEFENSE
Patricio Atanes from Biofarma Group exposed the thesis: "Estudio de la funcionalidad de GPCRs mediante el uso de herramientas biológicas y químicas: aplicación a los
receptores 5-HT2A y 5-HT7 de serotonina". Location: Graduate Hall School of Pharmacy (Santiago de Compostela).
Published en Web (30/07/2013)
Ainhoa Nieto Thesis: Estudio farmacológico de la modulación del receptor 5-HT2B de
serotonina por inhibidores selectivos de la COX-2 (celecoxib y valdecoxib) y fluoxetina
10th July 2013
THESIS DEFENSE
Date:10th July.
Ainhoa Nieto from Biofarma Group exposed the thesis:
"Estudio farmacológico de la modulación del receptor 5-HT2B de serotonina por inhibidores selectivos de la COX-2 (celecoxib y valdecoxib) y
fluoxetina" Location: Graduate Hall School of Pharmacy (Santiago de Compostela).
Published en Web (10/07/2013)
Visión actual de las quimiotecas para el descubrimento temprano de fármacos
10th July 2013
Joan Ballesteros PhD. Jordi Mestres PhD. Alejandro Pazos PhD.
Round-Table: "Visión actual de las quimiotecas para el descubrimento temprano de fármacos". Location: School of Pharmacy (Santiago de Compostela).
3rd European Chemical Biology Symposium/ 2nd Vienna Drug Action Conference.
3rd July 2012
Mabel Loza PhD participated in: 3rd European Chemical Biology Symposium/ 2nd Vienna Drug Action Conference. Location: Vienna.
Published en Web (4/07/2012)
5 sentidos para innovar
22nd March 2012
Jose Manuel Santamaría and Jose Brea PhD participated in: "5 sentidos para innovar"Tecnolope Location: San Cibrao das Viñas.
Published en Web (14/03/2012)
Héctor Caruncho: Investigando la depresión: De modelos animales al desarrollo de
biomarcadores.
24th January 2012
Héctor Caruncho.
Seminar:"Investigando la depresión: De modelos animales al desarrollo de biomarcadores". Location: CIMUS Building (Santiago de Compóstela).
Published en Web (18/04/2012)
Ainhoa Nieto PhD and
Patricio Atanes PhD were awarded in the XXXIII Spanish Congress of Farmacology
6th October 2011
AWARD
Two members of the BioFarma Group (Ainhoa Nieto PhD and
Patricio Atanes PhD) were awarded in the XXXIII
Spanish Congress of Farmacology that was held in Malaga.
Published en Web (7/10/2011)
Inauguration of the Mixed Unit Esteve - BioFarma.
4th October 2011
Inauguration of the Mixed Unit Esteve - BioFarma with the presence of Antoni Esteve , Pilar Farjas , Ricardo Capilla , Juan José Casares Long and Mabel
Loza. Location: Emprendia Building (Santiago de Compostela).
Published en Web (7/11/2011)
XXXIII Congreso de la Sociedad española de farmacología
3rd October 2011
The Biofarma Group participated in: XXXIII Congreso de la Sociedad española de farmacología. Location: Málaga.
Published en Web (22/07/2011)
Miptec 2011
19th September 2011
The Biofarma Group participated in Miptec 2011. Location: Basilea.
The Biofarma Group assisted to:
Screening Europe. Location: Hamburg.
Published en Web (18/04/2011)
CNIC High Content Scrrening Workshop.
20th June 2011
The Biofarma Group participated in: CNIC High Content Scrrening Workshop. Location: Madrid.
Published en Web (21/06/2011)
III Jornadas Bienales de Jóvenes Investigadores en
Proteómica
9th June 2011
The Biofarma Group participated in: III Jornadas Bienales de Jóvenes Investigadores en Proteómica. Location: Chemistry builing (Santiago de Compostela)
Published en Web (10/06/2011)
IV International Symposium on BIOMEDICAL INFORMATICS IN EUROPE
6th June 2011
Dr. Mabel Loza participated as speaker in: IV International Symposium on BIOMEDICAL INFORMATICS IN EUROPE Location: A Coruña.
Jordi Quintana (PCB).
Seminar : "La química biológica y la construcción de quimiotecas públicas, ChemBioBank y EU-OPENSCREEN".
Published en Web (24/05/2011)
María José Valera Thesis Defense
26th may 2011
THESIS DEFENSE
María José Valera from Biofarma Group exposed the Thesis Defense: "Estudio del ratón heterocigoto reeler como modelo animal in vitro de la esquizofrenia. Caracterización farmacológica de los receptores
D2 y 5-HT2A"
Published en Web (24/05/2011)
XXI Curso avanzado para postgraduados sobre receptores para neurotransmisores
9th may 2011
The Biofarma Group assisted to: XXI Curso avanzado para postgraduados sobre receptores para neurotransmisores.
Published en Web (11/04/2011)
Drug Discovery; Targets & Tools: GPCRs 2011
21st March 2011
The Biofarma Group assisted to: Drug Discovery; Targets & Tools: GPCRs 2011.
Published en Web (14/03/2011)
IV Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica
XXXI Congreso de Sociedad Española de Farmacología
15th September 2010
The Biofarma Group assisted to: XXXI Congreso de Sociedad Española de Farmacología Location: León.
Published en Web (26/05/2010)
Drug Discovery´10
1st September 2010
The Biofarma Group assisted to: Drug Discovery´10 Location: Coventry (UK).
Published en Web (30/05/2010)
2nd European Chemical Biology Simposium
20th May 2010
The Biofarma Group assisted to: 2nd European Chemical Biology Simposium Location: Prague.
Published en Web (10/05/2010)
8th Annual G Protein-Coupled Receptors
17th March 2010
The Biofarma Group assisted to: 8th Annual G Protein-Coupled Receptors.
Published en Web (10/03/2010)
III Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica
23th February 2010
The Biofarma Group assisted to: III Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica: Medicamentes Innovadores, Nanomedicina y tecnología Sanitaria. Fomentando
la colaboración público-privada
Published en Web (20/02/2010)
Screening europe
11st February 2010
The Biofarma Group assisted to: Screening europe. Location : Barcelona.
Published en Web (10/02/2010)
Jornada sobre la colaboración público-privada para el descubrimiento de fármacos en
España
Opening act in the Emprendia building with several authorities as the science secretary, Cristina Garmendia, the President of
Xunta de Galicia, Alberto Núñez Feijóo, the USC principal Senén Barro, The Education secretary, Jesús
Vázquez,The Mayor in Santiago de Compostela , Xosé A. Sánchez Bugallo, the Unviersities– secretary, Marius Rubiralta and the
president in a Deputación de A Coruña,Salvador Fernández Moreda.
Published en Web (4/11/2009)
Enfoques moleculares innovadores a la farmacología de los antipsicóticos
15th October 2009
Project granted to Biofarma Group:
Title : Enfoques moleculares innovadores a la farmacología de los antipsicóticos.
Financial Institution: Ministerio de Ciencia e Innovación.
Principal Researcher : María Isabel Loza García.
Published en Web (15/09/2009)
Cribado farmacológico de fármacos neurogénicos como tratamiento innovador de enfermedades neurodegenerativas
Title : Cribado farmacológico de fármacos neurogénicos como tratamiento innovador de enfermedades neurodegenerativas.
Financial Institution: Ministerio de Ciencia e Innovación.
Principal Researcher: María Isabel Cadavid Torres.
Published en Web (15/09/2009)
Eduardo Domínguez and Enrique Saez Conferences
5th October 2009
Enrique Saez PhD.
Conference:"Phenotypic screening of adipocytes to identify novel therapeutic approaches to metabolic disorders".
Eduardo Domínguez PhD.
Conference:"Chemogenomic analysis of adipogenesis using traceable chemical probes and functional proteomics".
Published en Web (29/09/2009)
New approaches to study GPR35; a novel target for the treatment of diabetes
4th September 2009
G Milligan, Ph.D.
Conference: "New approaches to study GPR35; a novel target for the treatment of diabetes".
Published en Web (2/09/2009)
Natural Products as Source of Drugs: Scope and Limitations
4th September 2009
Fernando Albericio, Ph.D.
Conference: Natural Products as Source of Drugs: Scope and Limitations.
Published en Web (2/09/2009)
Identificación Mediante Proteómica De Biomarcadores Plaquetarios En Pacientes Con Síndrome Coronario
Agudo
8th August 2009
Mutua Madrileña foundation has confered to the Biofarma Group researcherÁngel García PhD the project: Identificación Mediante Proteómica De Biomarcadores Plaquetarios En Pacientes Con Síndrome Coronario Agudo.
The only project confered in this convocatory to the USC.
Published en Web (7/08/2009)
Mabel Loza has been joined in the Galician Academy of Pharmacys